The Infectious Disease Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the infectious disease therapeutics industry has been on a consistent growth trajectory. It is anticipated to expand from a size of $141.08 billion in 2024 to $151.04 billion in 2025. The compound annual growth rate of this market is projected to be 7.1%.
The Infectious Disease Therapeutics market is anticipated to increase to a value of $196.5 billion in 2029, with a compound annual growth rate (CAGR) of 6.8%.
Download Your Free Sample of the 2025 Infectious Disease Therapeutics Market Report and Uncover Key Trends Now!The drivers in the infectious disease therapeutics market are:
• Rising prevalence of infectious and viral diseases
• Increasing awareness about diagnosis and antimicrobial stewardship
• Rising demand for quick and efficient diagnostic testing
• Growing demand for cost-effective generic drugs
The infectious disease therapeutics market covered in this report is segmented –
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users
The trends in the infectious disease therapeutics market are:
• Partnerships within the sector are a prominent emerging trend.
• Increasing product approvals are shaping the future of the market.
• Investments in the infectious disease therapeutics sector are an important trend.
• There is a noteworthy trend of increased research and development in therapeutics.
The major players in the infectious disease therapeutics market are:
• Pfizer Inc.
North America was the largest region in the infectious disease therapeutics market in 2023